Solomon Moshkevich, PRESIDENT, CLINICALDIAGNOSTICS at Natera, Inc. (NTRA), sold 6,000 shares at $198.83 ($1.2M) on 2026-03-02, disclosed to the SEC on 2026-03-03.
Open-market sale of $1.2M NTRA by PRESIDENT, CLINICALDIAGNOSTICS. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $198.83 | 931 | $185K | 15.4% |
| 2 | $198.83 | 931 | $185K | 15.4% |
| 3 | $200.11 | 1,594 | $319K | 26.6% |
| 4 | $200.11 | 1,594 | $319K | 26.6% |
| 5 | $200.97 | 475 | $95K | 8.0% |
| 6 | $200.97 | 475 |
| $95K |
| 8.0% |
| Total | $199.85 avg | 6,000 | $1.2M | 100% |
| Filing → |
| NTRA | SELL | 2026-08-05 | $906K | — | Filing → |
| NTRA | SELL | 2026-07-29 | $569K | — | Filing → |
| NTRA | SELL | 2026-07-06 | $819K | — | Filing → |